Achieving strong optimization generalization across diverse optimization problems while requiring limited training resources remains a challenging problem for optimization-oriented large language models (LLMs). Existing learning-based methods, however, typically require large-scale supervised data, expensive intermediate step verification, and extensive computational resources, while exhibiting limited optimization generalization across diverse optimization structures. In this paper, we propose \textsc{MiniOpt}, a lightweight optimization-specialized LLM trained through a reasoning-to-model-and-solve paradigm and a two-stage training framework with reinforcement learning with verifiable rewards (RLVR). MiniOpt encourages structure-oriented optimization learning by reinforcing the completeness of optimization formulations and optimization outcomes. Extensive experiments on eight optimization benchmarks demonstrate that MiniOpt consistently outperforms existing learning-based optimization models while requiring substantially fewer parameters and training data. To further understand optimization generalization, we introduce a complementary parameter-decoupled evaluation protocol that disentangles optimization structure understanding from numerical parameter processing. The results reveal that MiniOpt preserves optimization capability under parameter-decoupled settings significantly better than previous optimization-specialized models, suggesting that its performance gains primarily originate from stronger optimization structure understanding. These findings demonstrate an effective pathway toward efficient and generalizable optimization-specialized LLMs. The code is available at https://github.com/Hsiang-1/MiniOpt.
To keep long interaction contexts tractable, stepwise group-relative training for multi-turn LLM agents materializes each source trajectory into multiple response rows and valid tokens. This expansion creates an outer-accounting problem distinct from within-trajectory credit assignment: row-based outcome statistics can count one episode outcome multiple times, while token-level reduction can assign unequal aggregate objective mass across trajectories. We term these effects outcome-statistics multiplicity and objective-mass imbalance. We introduce Outcome-Mass Alignment (OMA), a two-component method that makes both accounting choices explicit. Outcome Alignment computes outcome statistics over unique source trajectories, while Mass Alignment controls aggregate objective mass after within-trajectory aggregation of optimizer-native token objectives. Neither redesigns the base optimizer's credit assignment, importance ratios, or clipping. Across matched ALFWorld GRPO comparisons at two model scales, where failed trajectories typically expand much more than successful ones, OMA improves matched-horizon endpoint success by 7.0-9.4 percentage points. Ordinary WebShop exhibits weak or reversed expansion-outcome coupling and correspondingly mixed effects, whereas in a success-oriented WebShop setting, WebShop-SOL, OMA improves success nAUC from 0.399 to 0.511. Component ablations and GiGPO and GSPO comparisons further support component separability and cross-optimizer compatibility. These results show that trajectory expansion always defines an implicit weighting rule, but its practical effect depends on how expansion couples to outcomes and optimizer-native updates.
Clinical genomic analysis requires experts to integrate evolving guidelines, databases, and computational evidence. As sequencing has become increasingly accessible, this complex and labor-intensive process has become a major bottleneck to the timely use of genomic information in clinical decision-making. To fill this gap, we developed ClinGeX, a large-language-model agent that composes 105 curated executable skills through task-specific retrieval and dependency-aware orchestration. On 223 temporally held-out benchmark cases, ClinGeX achieved 71.7\% macro-averaged task-level concordance with expert reference classifications, compared with 45.7\% for the strongest comparator. In a three-condition, counterbalanced human-AI collaboration study, 45 clinical genomic professionals assessed 135 clinically derived cases under routine (no AI assistance), DeepSeek-assisted and ClinGeX-assisted conditions. ClinGeX assistance increased raw case-level concordance across criterion-level variant analysis, genomic interpretation in rare disease and molecular oncology decision-making (51.1\%, 57.8\%, 64.4\% versus 15.6\%, 31.1\%, 20.0\% in comparator conditions) and reduced reported interpretation time in all scenarios. During an exploratory one-month real-world non-interventional assessment, 11 experienced professionals submitted feedback on 96 self-selected analysis episodes and reported frequent conclusion adoption and time savings. These findings support executable domain skills as a promising approach to augment specialist genomic interpretation.